Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 23,618Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12Merck Sharp & Dohme Bv

02 2Msd Merck Sharp & Dohme Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutamic Acid; Metformin Hydrochloride

Brand Name : The Segluromet

Dosage Form : Film Coated Tablet

Dosage Strength : 2.5mg;1000mg

Packaging :

Approval Date : 23/03/2018

Application Number : 20170130000035

Regulatory Info : Approved

Registration Country : Sweden

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutamic Acid; Metformin Hydrochloride

Brand Name : The Segluromet

Dosage Form : Film Coated Tablet

Dosage Strength : 2.5mg;850mg

Packaging :

Approval Date : 23/03/2018

Application Number : 20170130000028

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutamic Acid; Metformin Hydrochloride

Brand Name : The Segluromet

Dosage Form : Film Coated Tablet

Dosage Strength : 7.5mg;1000mg

Packaging :

Approval Date : 23/03/2018

Application Number : 20170130000059

Regulatory Info : Approved

Registration Country : Sweden

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutamic Acid; Metformin Hydrochloride

Brand Name : The Segluromet

Dosage Form : Film Coated Tablet

Dosage Strength : 7.5mg;850mg

Packaging :

Approval Date : 23/03/2018

Application Number : 20170130000042

Regulatory Info : Approved

Registration Country : Sweden

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutamic Acid; Sitagliptin Phosphate Monohydrate

Brand Name : Steglujan

Dosage Form : Film Coated Tablet

Dosage Strength : 15mg;100mg

Packaging :

Approval Date : 23/03/2018

Application Number : 20170202000086

Regulatory Info : Approved

Registration Country : Sweden

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutamic Acid; Sitagliptin Phosphate Monohydrate

Brand Name : Steglujan

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg;100mg

Packaging :

Approval Date : 23/03/2018

Application Number : 20170202000062

Regulatory Info : Approved

Registration Country : Sweden

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutaminesyra

Brand Name : Steglatro

Dosage Form : Film Coated Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 21/03/2018

Application Number : 20170203000030

Regulatory Info : Approved

Registration Country : Sweden

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin-L-Pyroglutaminesyra

Brand Name : Steglatro

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 21/03/2018

Application Number : 20170203000023

Regulatory Info : Approved

Registration Country : Sweden

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin

Brand Name : Steglatro

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 18/10/2018

Application Number : 66577

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ertugliflozin; Sitagliptin

Brand Name : Steglujan mg

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg;100mg

Packaging :

Approval Date : 18/10/2018

Application Number : 66578

Regulatory Info : Allowed

Registration Country : Switzerland

blank